Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 10/20 | 0.51 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.47 |
| ▸ | CTSD | P07339 | 2/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.45 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.45 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.45 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.45 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.45 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.45 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.44 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.43 |
| ▸ | GLP1R | P43220 | 1/20 | 0.43 |
| ▸ | GCGR | P47871 | 1/20 | 0.43 |
| ▸ | GIPR | P48546 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29386588 | 1.00 | BACE1 (0.51) | BACE1BACE2CTSDGRIN2DGRIN3B | |
| SCHEMBL29973381 | 1.00 | BACE1 (0.51) | BACE1BACE2CTSDGRIN2DGRIN3B | |
| SCHEMBL29711237 | 0.98 | BACE1 (0.49) | BACE1BACE2CTSDGRIN2DGRIN3B | |
| SCHEMBL30512635 | 0.93 | BACE1 (0.46) | BACE1BACE2CTSDGRIN2DGRIN3B | |
| SCHEMBL30578948 | 0.90 | BACE1 (0.43) | BACE1BACE2CTSD | |
| SCHEMBL30842794 | 0.89 | BACE1 (0.46) | BACE1CTSD | |
| SCHEMBL30242246 | 0.88 | FOLH1 (0.43) | BACE1BACE2CTSDGRIN2DGRIN3B | |
| SCHEMBL31341151 | 0.88 | BACE1 (0.56) | BACE1BACE2CTSD | |
| SCHEMBL30974509 | 0.88 | GRIN2D (0.56) | BACE1BACE2CTSDGRIN2DGRIN3B | |
| SCHEMBL30512779 | 0.87 | BACE1 (0.52) | BACE1BACE2CTSDGRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12409205-B2 | Nanomolecules for the treatment of inflammatory bowel diseases | NORTHWESTERN UNIVERSITY (US) | 2025-09-09 | — | — | US | claimed |
| EP-2964658-B1 | POSITRON-EMITTING SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS | UNIV BRITISH COLUMBIA (CA) | 2024-08-07 | — | — | EP | claimed |
| US-20220048952-A1 | ANTI-INFLAMMATORY NANOFIBERS | NORTHWESTERN UNIVERSITY | 2022-02-17 | — | — | US | claimed |
| EP-4707410-A2 | REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS | California Institute of Technology (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20250375486-A1 | REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS | CALIFORNIA INST OF TECHN (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250281440-A1 | METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE | NUTRIQUEST, LLC | 2025-09-11 | — | — | US | disclosed |
| US-12409205-B2 | Nanomolecules for the treatment of inflammatory bowel diseases | NORTHWESTERN UNIVERSITY (US) | 2025-09-09 | — | — | US | disclosed |
| US-12329786-B2 | Regulate gut microbiota to treat neurodegenerative disorders | CALIFORNIA INSITUTE OF TECHNOLOGY (US) | 2025-06-17 | — | — | US | disclosed |
| EP-3782649-B1 | BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS | ASCENDIS PHARMA AS (DK) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025097053-A1 | DANDELION EXTRACT TO IMPROVE REPRODUCTIVE PERFORMANCE IN ANIMALS AND METHODS OF USE | NUTRIQUEST, LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| US-20250057191-A1 | METHODS OF IMPROVING THE NUTRITIONAL STATUS OF IMMUNE STRESSED ANIMALS | ELANCO US INC (US) | 2025-02-20 | — | — | US | disclosed |
| US-11559482-B2 | Biodegradable polyethylene glycol based water-insoluble hydrogels | ASCENDIS PHARMA A/S (DE) | 2023-01-24 | — | — | US | disclosed |
| US-20220354823-A1 | SWINE MATERNAL NEONATAL PHEROMONE | TEXAS TECH UNIVERSITY SYSTEM (US) | 2022-11-10 | — | — | US | disclosed |
| US-20220338504-A1 | FEED ADDITIVE COMPOSITIONS | ELANCO US INC. | 2022-10-27 | — | — | US | disclosed |
| EP-4030925-A1 | SWINE MATERNAL NEONATAL PHEROMONE | Texas Tech University System (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4011396-A1 | RELEASABLE CONJUGATES | QuiaPEG Pharmaceuticals AB (SE) | 2022-06-15 | — | — | EP | disclosed |
| WO-2022103996-A1 | CLAY COMPOSITIONS AND METHODS FOR IMPROVING ANIMAL PERFORMANCE | NUTRIQUEST, LLC (US) | 2022-05-19 | — | — | WO | disclosed |
| US-20220142204-A1 | CLAY COMPOSITIONS AND METHODS FOR IMPROVING ANIMAL PERFORMANCE | NUTRIQUEST, LLC (US) | 2022-05-12 | — | — | US | disclosed |
| EP-3975746-A1 | THERAPEUTIC CLAY COMPOSITIONS AND METHODS OF USING | Nutriquest, LLC (US) | 2022-04-06 | — | — | EP | disclosed |
| US-20220048952-A1 | ANTI-INFLAMMATORY NANOFIBERS | NORTHWESTERN UNIVERSITY | 2022-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250281440-A1 | METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE | PIGS, GLO1, IGFBP6 | BACE1 4316/4885BACE2 3892/4885CTSD 2058/4885 |
| US-11559482-B2 | Biodegradable polyethylene glycol based water-insoluble hydrogels | PLG, PHYKPL, PLOD3 | BACE1 4242/4885BACE2 4207/4885CTSD 1438/4885 |
| US-12409205-B2 | Nanomolecules for the treatment of inflammatory bowel diseases | VIP, IAPP, NOD2 | BACE1 801/4885BACE2 1197/4885CTSD 1742/4885 |
| US-20220354823-A1 | SWINE MATERNAL NEONATAL PHEROMONE | PIGS, KISS1R, PGF | BACE1 324/4885BACE2 824/4885CTSD 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.